A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction

American Journal of Obstetrics and Gynecology

Volumn 192, Issue 3, 2005, Pages 694-708

  Howley, Heather E A ^a   Walker, Mark ^b   Rodger, Marc A ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Factor V Leiden; Intrauterine growth restriction; Meta analysis; Prothrombin gene variant

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT;

EID: 14644435132     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.09.011     Document Type: Review

References (72)

1. M.S. Kramer, M. Olivier, F.H. McLean, D.M. Willis, and R.H. Usher Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcome Pediatrics 86 1990 707 713
2. D.D. McIntire, S.L. Bloom, B.M. Casey, and K.J. Leveno Birth weight in relation to morbidity and mortality among newborn infants N Engl J Med 340 1999 1234 1238
3. B. Guyer, D.L. Hoyert, J.A. Martin, S.J. Ventura, M.F. MacDorman, and D.M. Strobino Annual summary of vital statistics: 1998 Pediatrics 104 1999 1229 1246
4. M.S. Kramer, R.W. Platt, S.W. Wen, K.S. Joseph, A. Allen, and M. Abrahamowicz A new and improved population-based Canadian reference for birth weight for gestational age [abstract] Pediatrics 108 2001 E35
5. R.S. Strauss, and W.H. Dietz Growth and development of term children born with low birth weight: effects of genetic and environmental factors J Pediatr 133 1998 67 72
6. R.S. Strauss Effects of the intrauterine environment on childhood growth Br Med Bull 53 1997 81 95
7. R.S. Strauss, and W.H. Dietz Effects of intrauterine growth retardation in premature infants on early childhood growth J Pediatr 130 1997 95 102
8. R.S. Strauss Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort JAMA 283 2000 625 632
9. M. Hack, D.J. Flannery, M. Schluchter, L. Cartar, E. Borawski, and N. Klein Outcomes in young adulthood for very-low-birth-weight infants N Engl J Med 346 2002 149 157
10. D.J. Barker Fetal origins of cardiovascular disease Ann Med 31 suppl 1999 3 6
11. D.J. Barker, P.D. Winter, C. Osmond, B. Margetts, and S.J. Simmonds Weight in infancy and death from ischaemic heart disease Lancet 2 1989 577 580
12. M.S. Kramer Determinants of low birth weight: methodological assessment and meta-analysis Bull World Health Organ 65 1987 663 737
13. F.J. van der Meer, T. Koster, J.P. Vandenbroucke, E. Briet, and F.R. Rosendaal The Leiden thrombophilia study (LETS) Thromb Haemost 78 1997 631 635
14. S.R. Poort, F.R. Rosendaal, P.H. Reitsma, and R.M. Bertina A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
15. B.L. Sheppard, and J. Bonnar Uteroplacental hemostasis in intrauterine fetal growth retardation Semin Thromb Hemost 25 1999 443 446
16. U. Kjellberg, N.E. Andersson, S. Rosen, L. Tengborn, and M. Hellgren APC resistance and other haemostatic variables during pregnancy and puerperium Thromb Haemost 81 1999 527 531
17. A. Many, L. Schreiber, S. Rosner, J.B. Lessing, A. Eldor, and M.J. Kupferminc Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia Obstet Gynecol 98 2001 1041 1044
18. B. Brenner, and M.J. Kupferminc Inherited thrombophilia and poor pregnancy outcome Best Pract Res Clin Obstet Gynaecol 17 2003 427 439
19. E. Grandone, and M. Margaglione Inherited thrombophilia and gestational vascular complications Best Pract Res Clin Haematol 16 2003 321 332
20. B. Brenner Thrombophilia and pregnancy loss Thromb Res 108 2002 197 202
21. V. De Stefano, E. Rossi, K. Paciaroni, and G. Leone Screening for inherited thrombophilia: indications and therapeutic implications Haematologica 87 2002 1095 1108
22. D. Roberts, and R.S. Schwartz Clotting and hemorrhage in the placenta: a delicate balance N Engl J Med 347 2002 57 59
23. D. Bloomenthal, P. von Dadelszen, R. Liston, L. Magee, and P. Tsang The effect of factor V Leiden carriage on maternal and fetal health CMAJ 167 2002 48 54
24. D. Bloomenthal, M.F. Delisle, F. Tessier, and P. Tsang Obstetric implications of the factor V Leiden mutation: a review Am J Perinatol 19 2002 37 47
25. C.J. Lockwood Inherited thrombophilias in pregnant patients: detection and treatment paradigm Obstet Gynecol 99 2002 333 341
26. L.L. Peeters Thrombophilia and fetal growth restriction Eur J Obstet Gynecol Reprod Biol 95 2001 202 205
27. V. Spina, V. Aleandri, and F. Morini The impact of the factor V Leiden mutation on pregnancy Hum Reprod Update 6 2000 301 306
28. I.A. Greer Thrombosis in pregnancy: maternal and fetal issues Lancet 353 1999 1258 1265
29. B.M. Sibai Thrombophilias and adverse outcomes of pregnancy: What should a clinician do? N Engl J Med 340 1999 50 52
30. Z. Alfirevic, D. Roberts, and V. Martlew How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review Eur J Obstet Gynecol Reprod Biol 101 2002 6 14
31. F. Franchi, I. Cetin, T. Trodos, P. Antonazzo, M.S. Nobile de Santois, and E. Piccoli Intrauterine growth restriction and thrombophilic polymorphisms [abstract] J Thromb Haemost 1 Suppl 2003 P0353
32. L.M. McCowan, S. Craigie, R.S. Taylor, C. Ward, C. McLintock, and R.A. North Inherited thrombophilias are not increased in "idiopathic" small-for- gestational-age pregnancies Am J Obstet Gynecol 188 2003 981 985
33. D. Ogunyemi, W. Ku, and Y. Arkel The association between inherited thrombophilia, antiphospholipid antibodies and lipoprotein a levels with obstetrical complications in pregnancy J Thromb Thrombolysis 14 2002 157 162
34. C. Infante-Rivard, G.E. Rivard, W.V. Yotov, E. Genin, M. Guiguet, and C. Weinberg Absence of association of thrombophilia polymorphisms with intrauterine growth restriction N Engl J Med 347 2002 19 25
35. M.J. Kupferminc, A. Many, A. Bar-Am, J.B. Lessing, and J. Ascher-Landsberg Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia BJOG 109 2002 1373 1376
36. T. Agorastos, A. Karavida, A. Lambropoulos, T. Constantinidis, S. Tzitzimikas, and S. Chrisafi Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome J Matern Fetal Neonatal Med 12 2002 267 273
37. E. Verspyck, C.D. Le, F. Goffinet, F. Tron, L. Marpeau, and J.Y. Borg Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants BJOG 109 2002 28 33
38. P. Martinelli, E. Grandone, D. Colaizzo, D. Paladini, N. Scianname, and M. Margaglione Familial thrombophilia and the occurrence of fetal growth restriction Haematologica 86 2001 428 431
39. M.J. Kupferminc, H. Peri, E. Zwang, Y. Yaron, I. Wolman, and A. Eldor High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss Acta Obstet Gynecol Scand 79 2000 963 967
40. M.J. Kupferminc, A. Eldor, N. Steinman, A. Many, A. Bar-Am, and A. Jaffa Increased frequency of genetic thrombophilia in women with complications of pregnancy N Engl J Med 340 1999 9 13
41. M. Lee, C. Oddoux, J. Maturi, L. O'Neill, E.F. Funai, and H. Ostrer Factor V Leiden and prothrombin 20210 G-A mutations in association with severely growth restricted pregnancies [abstract] Am J Obstet Gynecol 184 2001 S131
42. E. Grandone, D. Colaizzo, V. Brancaccio, A. Ciampa, G. Di Minno, and M. Margaglione Impact of prothrombotic mutations and family history on the occurrence of intra-uterine fetal deaths Haematologica 87 2002 1118 1119
43. J. Rigo Jr., B. Nagy, L. Fintor, J. Tanyi, A. Beke, and I. Karadi Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5, 10 methylenetetrahydrofolate reductase Hypertens Pregnancy 19 2000 163 172
44. R. Hillermann, G.S. Gebhardt, R. Isaacs, D.W. Steyn, and H.J. Odendaal Mutations in prothrombin and factor V genes do not contribute significantly to placental vasculopathy in a high-risk patient cohort in South Africa S Afr Med J 92 2002 526 527
45. E. Grandone, M. Margaglione, D. Colaizzo, G. Pavone, D. Paladini, and P. Martinelli Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations Haematologica 87 2002 177 181
46. J.C. Livingston, J.R. Barton, V. Park, B. Haddad, O. Phillips, and B.M. Sibai Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia Am J Obstet Gynecol 185 2001 153 157
47. R. von Kries, R. Junker, D. Oberle, A. Kosch, and U. Nowak-Gottl Foetal growth restriction in children with prothrombotic risk factors Thromb Haemost 86 2001 1012 1016
48. C.L. Delle, D. Gramellini, G. Piantelli, C. Manotti, S. Fieni, and E. Vadora Doppler velocimetry and thrombophilic screening at middle trimester of gestation: preliminary data Eur J Obstet Gynecol Reprod Biol 99 2001 38 46
49. C.J. De Groot, K.W. Bloemenkamp, E.J. Duvekot, F.M. Helmerhorst, R.M. Bertina, and M.F. Van Der Preeclampsia and genetic risk factors for thrombosis: a case-control study Am J Obstet Gynecol 181 1999 975 980
50. W. Gopel, D. Kim, and L. Gortner Prothrombotic mutations as a risk factor for preterm birth Lancet 353 1999 1411 1412
51. C. Lindoff, I. Ingemarsson, G. Martinsson, M. Segelmark, H. Thysell, and B. Astedt Preeclampsia is associated with a reduced response to activated protein C Am J Obstet Gynecol 176 1997 457 460
52. H. Roque, M. Paidas, A. Rebarber, J. Maturi, L. O'Neill, and E. Kuczynski Maternal thrombophilia is associated with second and third trimester fetal death [abstract] Am J Obstet Gynecol 184 2001 S27
53. C.J. Glueck, H. Phillips, D. Cameron, P. Wang, R.N. Fontaine, and S.K. Moore The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications Metabolism 49 2000 845 852
54. R.P. Murphy, C. Donoghue, R.J. Nallen, M. D'Mello, C. Regan, and A.S. Whitehead Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy Arterioscler Thromb Vasc Biol 20 2000 266 270
55. P.G. Lindqvist, P.J. Svensson, K. Marsaal, L. Grennert, M. Luterkort, and B. Dahlback Activated protein C resistance (FV:Q506) and pregnancy Thromb Haemost 81 1999 532 537
56. O. Salomon, R. Achiron, Y. Zalel, D.M. Steinberg, A. Lerner, and N. Rosenberg Common inherited and acquired thrombophilias in unselected pregnant women do not compromise blood flow in the feto-maternal placental unit, and have no effect on the frequencies of preeclampsia and fetal growth retardation [abstract] Blood 11 suppl 2002 A1048
57. M.E. Spaanderman, R. Aardenburg, T.H. Ekhart, H.W. van Eyndhoven, O.W. van der Heijden, and J. van Eyck Non-pregnant circulatory volume status predicts subsequent pregnancy outcome in normotensive thrombophilic formerly preeclamptic women Eur J Obstet Gynecol Reprod Biol 95 2001 218 221
58. H.A. Mousa, and Z. Alfirevic Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 15 2000 1830 1833
59. J. Tzafettas, A. Mamopoulos, A. Anapliotis, A. Loufopoulos, A. Psarra, and N. Klearchou Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology Clin Exp Obstet Gynecol 29 2002 267 270
60. J.M. Sikkema, A. Franx, H.W. Bruinse, N.G. van der Wijk, H.W. de Valk, and P.G. Nikkels Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia Placenta 23 2002 337 342
61. F. Arias, R. Romero, H. Joist, and F.T. Kraus Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta J Matern Fetal Med 7 1998 277 286
62. N. Riyazi, M. Leeda, J.I. de Vries, P.C. Huijgens, H.P. van Geijn, and G.A. Dekker Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study Eur J Obstet Gynecol Reprod Biol 80 1998 49 54
63. E. Erhardt, J. Stankovics, D. Molnar, K. Adamovich, and B. Melegh High prevalence of factor V Leiden mutation in mothers of premature neonates Biol Neonate 78 2000 145 146
64. J.D. Wisotzkey, P. Bayliss, E. Rutherford, and T. Bell Placental genotyping of the factor V Leiden, prothrombin 20210A and the methylenetetrahydrofolate reductase (MTHFR) C677T alleles in IUGR pregnancies Thromb Haemost 81 1999 844 845
65. P. Clark, I.D. Walker, and I. Greer Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight Lancet 353 1999 292 293
66. S. Rotmensch, M. Liberati, M. Mittlemann, and Z. Ben Rafael Activated protein C resistance and adverse pregnancy outcome Am J Obstet Gynecol 177 1997 170 173
67. J.I. de Vries, G.A. Dekker, P.C. Huijgens, C. Jakobs, B.M. Blomberg, and H.P. van Geijn Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies BJOG 104 1997 1248 1254
68. P. Lindqvist, B. Dahlback, and K. Marsal Thrombotic risk during pregnancy: a population study Obstet Gynecol 94 1999 595 599
69. G.A. Dekker, J.I. de Vries, P.M. Doelitzsch, P.C. Huijgens, B.M. von Blomberg, and C. Jakobs Underlying disorders associated with severe early-onset preeclampsia Am J Obstet Gynecol 173 1995 1042 1048
70. D.J. Schaid, and S.J. Jacobsen Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions Am J Epidemiol 149 1999 706 711
71. C.B. Begg, and J.A. Berlin Publication bias and dissemination of clinical research J Natl Cancer Inst 81 1989 107 115
72. J.P.A. Ioannidis, T.A. Trikalinos, E.E. Ntzani, and D.G. Contopoulos-Ioannidis Genetic associations in large versus small studies: an empirical assessment Lancet 361 2003 561 567